KEITH ROBERT JEROME
Medical Practice at Eastlake Ave, Seattle, WA
License number
Washington MD00036076
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
825 Eastlake Ave EAST, Seattle, WA 98109
Phone
(206) 288-1000
(206) 543-6420
(206) 543-6420
Personal information
See more information about KEITH ROBERT JEROME at radaris.comName
Address
Phone
10316 Riviera Pl NE, Seattle, WA 98125
136 E 8Th St #258, Port Angeles, WA 98362
1911 SW Campus Dr #171, Federal Way, WA 98023
3005 NW 30Th Cir, Camas, WA 98607
3005 30Th Cir, Camas, WA 98607
Professional information
Keith Robert Jerome, Seattle WA
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine, Infectious Disease
Work:
Seattle Cancer Care Alliance
825 Eastlake Ave E, Seattle, WA 98109
825 Eastlake Ave E, Seattle, WA 98109
Education:
Duke University(1993)
President At Dealerstar
Location:
Greater Seattle Area
Industry:
Automotive
Dr. Keith R Jerome, Seattle WA - MD (Doctor of Medicine)
Specialties:
Clinical Pathology
Address:
825 Eastlake Ave E, Seattle 98109
(206) 288-1000 (Phone)
(206) 288-1000 (Phone)
Certifications:
Clinical Pathology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
825 Eastlake Ave E, Seattle 98109
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
Duke University
Graduated: 1993
University Of Washington
Duke University
Graduated: 1993
University Of Washington
Methods For Screening For Agents Capable Of Modulating T Lymphocyte Function In Response To A Herpes Simplex Virus-Infected Cell
US Patent:
2007015, Jul 5, 2007
Filed:
Nov 15, 2004
Appl. No.:
10/595840
Inventors:
Keith Jerome - Seattle WA, US
Derek Sloan - Seattle WA, US
Derek Sloan - Seattle WA, US
International Classification:
A61K 48/00, C12Q 1/70, A61K 39/395
US Classification:
424093210, 435005000, 424144100
Abstract:
Disclosed are methods for screening an agent for activity in modulating a T lymphocyte. The methods generally comprises contacting a HSV U3-expressing cell with a T lymphocyte in the presence or absence of the agent and monitoring a physiological change associated with CTL function to determine whether the agent modulates CTL activity. In particular, the HSV U3-expressing cell line can be a HSV-infected fibroblast and the physiological change associated with CTL function is a reduction or inhibition of the phosphorylation of HSP90 and/or a 50 kD CTL protein. Also disclosed are methods for blocking suppression of CTL activity against HSV-infected target cells, as well as methods for suppressing CTL activity against a target antigen.